Recommendation 15

The Government should continue to press for clarity from the United States on the conditions attached to future preferential access for UK pharmaceutical exports, and, where appropriate, secure wider tariff relief for scientific and medical products. Given the positive outcome secured for the aerospace sector, the Government should seek a similar resolution for pharmaceuticals, recognising that both are traditionally tariff-free sectors. (Recommendation, Paragraph 82)